Chinese FDI into Europe rose last year to US$81 billion because of the delayed regulatory approval for ChemChina’s US$43 billion takeover of Swiss agribusiness company Syngenta. Photo: AFP Chinese FDI into Europe rose last year to US$81 billion because of the delayed regulatory approval for ChemChina’s US$43 billion takeover of Swiss agribusiness company Syngenta. Photo: AFP
Chinese FDI into Europe rose last year to US$81 billion because of the delayed regulatory approval for ChemChina’s US$43 billion takeover of Swiss agribusiness company Syngenta. Photo: AFP
Investing

China’s investments into US fell 35pc in 2017 due to outflow curbs and tighter screening of deals

Two-thirds of the cancelled deals worth $12 billion in North America and Europe were caused by foreign regulatory intervention, study shows

Topic |   Investing
Chinese FDI into Europe rose last year to US$81 billion because of the delayed regulatory approval for ChemChina’s US$43 billion takeover of Swiss agribusiness company Syngenta. Photo: AFP Chinese FDI into Europe rose last year to US$81 billion because of the delayed regulatory approval for ChemChina’s US$43 billion takeover of Swiss agribusiness company Syngenta. Photo: AFP
Chinese FDI into Europe rose last year to US$81 billion because of the delayed regulatory approval for ChemChina’s US$43 billion takeover of Swiss agribusiness company Syngenta. Photo: AFP
READ FULL ARTICLE